Free Trial
OTC:NVZMY

Novonesis A/S (NVZMY) Stock Price, News & Analysis

$57.26 +0.73 (+1.29%)
(As of 11/20/2024 05:20 PM ET)

About Novonesis A/S Stock (OTC:NVZMY)

Key Stats

Today's Range
$56.77
$57.27
50-Day Range
N/A
52-Week Range
$49.99
$72.50
Volume
11,763 shs
Average Volume
13,426 shs
Market Capitalization
$26.81 billion
P/E Ratio
36.24
Dividend Yield
1.15%
Price Target
N/A
Consensus Rating
Sell

Company Overview

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Receive NVZMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novonesis A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

NVZMY Stock Analysis - Frequently Asked Questions

Novonesis A/S's stock was trading at $65.95 at the beginning of the year. Since then, NVZMY shares have decreased by 13.2% and is now trading at $57.26.
View the best growth stocks for 2024 here
.

Shares of NVZMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
CIK
N/A
Employees
6,756
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.60 billion
Cash Flow
$0.95 per share
Book Value
$4.45 per share

Miscellaneous

Free Float
N/A
Market Cap
$26.81 billion
Optionable
N/A
Beta
0.90
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (OTC:NVZMY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners